Opioids and dose-related deaths — association or causation? — Reply
Gomes T, Mamdani MM, Dhalla IA, Paterson JM, Juurlink DN. Arch Intern Med. 2011; 171(18):1687-9.
Publications
Trimethoprim-sulfamethoxazole induced hyperkalaemia in elderly patients receiving spironolactone: nested case-control study
Antoniou T, Gomes T, Mamdani MM, Yao Z, Hellings C, Garg AX, Weir MA, Juurlink DN. BMJ. 2011; 343:d5228 Epub 2011 Sep 12.
Statins and intracerebral hemorrhage: a retrospective cohort study
Hackam DG, Austin PC, Huang A, Juurlink DN, Mamdani MM, Paterson JM, Hachinski V, Li P, Kapral MK. Arch Neurol . 2011; 69(1):39-45. Epub 2011 Sep 12.
Beta-blockers and cardiovascular outcomes in dialysis patients: a cohort study in Ontario, Canada
Kitchlu A, Clemens K, Gomes T, Hackam DG, Juurlink DN, Mamdani M, Manno M, Oliver MJ, Quinn RR, Suri RS, Wald R, Yan AT, Garg AX. Nephrol Dial Transplant. 2012; 27(4):1591-8. Epub 2011 Aug 26.
Facing up to the prescription opioid crisis
Dhalla IA, Persaud N, Juurlink DN. BMJ. 2011; 343:d5142. Epub 2011 Aug 23.
Risk of serious falls associated with oxybutynin and tolterodine: a population based study
Gomes T, Juurlink DN, Ho JM, Schneeweiss S, Mamdani MM. J Urol. 2011; 186(4):1340-4. Epub 2011 Aug 18.
Selective serotonin reuptake inhibitors and pulmonary arterial hypertension: a case-control study
Dhalla IA, Juurlink DN, Gomes T, Granton JT, Zheng H, Mamdani MM. Chest. 2011; 141(2):348-53. Epub 2011 Aug 18.
The impact of federal warnings on publically funded desmopressin utilization among children in Ontario
Gomes T, Juurlink DN, Moore I, Maguire JL, Mamdani MM. J Pediatr Urol. 2012; 8(3):249-53. Epub 2011 Jul 20.
Comparative adherence to oxybutynin or tolterodine among older patients
Gomes T, Juurlink DN, Mamdani MM. Eur J Clin Pharmacol. 2012; 68(1):97-9. Epub 2011 Jun 28.
Bisphosphonate prescribing, persistence and cumulative exposure in Ontario, Canada
Burden AM, Paterson JM, Solomon DH, Mamdani M, Juurlink DN, Cadarette SM. Osteoporos Int. 2012; 23(3):1075-82. Epub 2011 May 21.